Dayspring Pharma announces phase 2 trial of CG2001 foam met primary endpoint in Chinese adult men with androgenetic alopecia
ImmunoForge to accelerate central nervous system drug development with innovative blood-brain barrier shuttle platform
Novo Nordisk to seek oral sickle cell therapy approval after phase 3 success
AI Drug Discovery & Development Summit (AIDDD)
Global Drug Delivery and Formulation (DDF) Summit
Chemspec Europe reveals new details about 2026 conference programme
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
Major growth in visitor numbers, full halls, clear future topics: Analytica 2026 sets standards
